These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30232265)

  • 21. Genetic requirements for uropathogenic
    Mediati DG; Blair TA; Costas A; Monahan LG; Söderström B; Charles IG; Duggin IG
    mSystems; 2024 Oct; 9(10):e0038724. PubMed ID: 39287381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of the amyloid dye Congo red on curli, cellulose, and the extracellular matrix in E. coli during growth and matrix purification.
    Reichhardt C; McCrate OA; Zhou X; Lee J; Thongsomboon W; Cegelski L
    Anal Bioanal Chem; 2016 Nov; 408(27):7709-7717. PubMed ID: 27580606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyroptosis engagement and bladder urothelial cell-derived exosomes recruit mast cells and induce barrier dysfunction of bladder urothelium after uropathogenic
    Wu Z; Li Y; Liu Q; Liu Y; Chen L; Zhao H; Guo H; Zhu K; Zhou N; Chai TC; Shi B
    Am J Physiol Cell Physiol; 2019 Sep; 317(3):C544-C555. PubMed ID: 31241987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.
    Eto DS; Jones TA; Sundsbak JL; Mulvey MA
    PLoS Pathog; 2007 Jul; 3(7):e100. PubMed ID: 17630833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37.
    Kai-Larsen Y; Lüthje P; Chromek M; Peters V; Wang X; Holm A; Kádas L; Hedlund KO; Johansson J; Chapman MR; Jacobson SH; Römling U; Agerberth B; Brauner A
    PLoS Pathog; 2010 Jul; 6(7):e1001010. PubMed ID: 20661475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon.
    Rafsanjany N; Senker J; Brandt S; Dobrindt U; Hensel A
    J Agric Food Chem; 2015 Oct; 63(40):8804-18. PubMed ID: 26330108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia.
    Vigil PD; Wiles TJ; Engstrom MD; Prasov L; Mulvey MA; Mobley HL
    Infect Immun; 2012 Feb; 80(2):493-505. PubMed ID: 22083710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressing the phenotypic virulence factors of Uropathogenic Escherichia coli using marine polysaccharide.
    Rubini D; Varthan PV; Jayasankari S; Vedahari BN; Nithyanand P
    Microb Pathog; 2020 Apr; 141():103973. PubMed ID: 31927002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.
    Acharya D; Sullivan MJ; Duell BL; Goh KGK; Katupitiya L; Gosling D; Chamoun MN; Kakkanat A; Chattopadhyay D; Crowley M; Crossman DK; Schembri MA; Ulett GC
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31776239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative proteomics of uropathogenic Escherichia coli during growth in human urine identify UCA-like (UCL) fimbriae as an adherence factor involved in biofilm formation and binding to uroepithelial cells.
    Wurpel DJ; Totsika M; Allsopp LP; Webb RI; Moriel DG; Schembri MA
    J Proteomics; 2016 Jan; 131():177-189. PubMed ID: 26546558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.
    Hannan TJ; Totsika M; Mansfield KJ; Moore KH; Schembri MA; Hultgren SJ
    FEMS Microbiol Rev; 2012 May; 36(3):616-48. PubMed ID: 22404313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high-throughput assay for the measurement of uropathogenic Escherichia coli attachment to urinary bladder cells.
    García Méndez KB; Bragagnolo G; O'Callaghan D; Lavigne JP; Keriel A
    Int J Exp Pathol; 2016 Apr; 97(2):194-201. PubMed ID: 27273601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of the EhaG and UpaG trimeric autotransporter proteins from pathogenic Escherichia coli.
    Totsika M; Wells TJ; Beloin C; Valle J; Allsopp LP; King NP; Ghigo JM; Schembri MA
    Appl Environ Microbiol; 2012 Apr; 78(7):2179-89. PubMed ID: 22286983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uropathogenic E. coli promote a paracellular urothelial barrier defect characterized by altered tight junction integrity, epithelial cell sloughing and cytokine release.
    Wood MW; Breitschwerdt EB; Nordone SK; Linder KE; Gookin JL
    J Comp Pathol; 2012 Jul; 147(1):11-9. PubMed ID: 22014415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration.
    Lau ME; Loughman JA; Hunstad DA
    Infect Immun; 2012 Dec; 80(12):4123-32. PubMed ID: 22966043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic role of curli and cellulose in cell adherence and biofilm formation of attaching and effacing Escherichia coli and identification of Fis as a negative regulator of curli.
    Saldaña Z; Xicohtencatl-Cortes J; Avelino F; Phillips AD; Kaper JB; Puente JL; Girón JA
    Environ Microbiol; 2009 Apr; 11(4):992-1006. PubMed ID: 19187284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uropathogenic Escherichia coli Express Type 1 Fimbriae Only in Surface Adherent Populations Under Physiological Growth Conditions.
    Stærk K; Khandige S; Kolmos HJ; Møller-Jensen J; Andersen TE
    J Infect Dis; 2016 Feb; 213(3):386-94. PubMed ID: 26290608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curli of Uropathogenic
    Luna-Pineda VM; Moreno-Fierros L; Cázares-Domínguez V; Ilhuicatzi-Alvarado D; Ochoa SA; Cruz-Córdova A; Valencia-Mayoral P; Rodríguez-Leviz A; Xicohtencatl-Cortes J
    Front Microbiol; 2019; 10():2063. PubMed ID: 31551993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orthosipon stamineus extract exerts inhibition of bacterial adhesion and chaperon-usher system of uropathogenic Escherichia coli-a transcriptomic study.
    Beydokhti SS; Stork C; Dobrindt U; Hensel A
    Appl Microbiol Biotechnol; 2019 Oct; 103(20):8571-8584. PubMed ID: 31501937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.
    Schilling JD; Mulvey MA; Vincent CD; Lorenz RG; Hultgren SJ
    J Immunol; 2001 Jan; 166(2):1148-55. PubMed ID: 11145696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.